According to Global Blue Group's latest financial reports the company's current earnings (TTM) are $51.78 M. In 2022 the company made an earning of -$54.67 M an increase over its 2021 earnings that were of -$0.17 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | $52.92 M | -196.82% |
2022 | -$54.67 M | -66.4% |
2021 | -$0.17 B | -67.36% |
2020 | -$0.5 B |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $21.36 B | 41,153.26% | ๐บ๐ธ USA |
![]() Medtronic MDT | $6.23 B | 11,940.17% | ๐ฎ๐ช Ireland |
![]() Boston Scientific BSX | $2.14 B | 4,049.85% | ๐บ๐ธ USA |
![]() Edwards Lifesciences EW | $1.62 B | 3,029.86% | ๐บ๐ธ USA |
![]() Stryker Corporation SYK | $3.91 B | 7,463.97% | ๐บ๐ธ USA |